Use of an h+, k+-atpase inhibitor in the treatment of nasal...

Details Use of an h+, k+-atpase inhibitor in the treatment of nasal... Use of an h+, k+-atpase inhibitor in the treatment of nasal...

A - Human Necessities

61

K

A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/415 (2006.01) A61K 31/4184 (2006.01) A61K 31/435 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/56 (2006.01) A61K 31/57 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2268305

The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+, K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.

L'invention concerne un procédé de traitement de polypose, consistant à traiter un sujet souffrant de polypose à l'aide d'un inhibiteur d'une H<+>, K<+>-ase, et éventuellement d'un glucocorticoïde. L'invention concerne également une formulation pharmaceutique destinée à une administration simultanée, séparée ou séquentielle, dans le traitement du syndrome de Widal et dans le traitement de l'asthme.

Affiliated with

Also associated with

Rating

Use of an h+, k+-atpase inhibitor in the treatment of nasal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of an h+, k+-atpase inhibitor in the treatment of nasal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an h+, k+-atpase inhibitor in the treatment of nasal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1892458